3.26

1.21% -0.04

Editas Medicine Inc (EDIT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché EDIT Giù? Forum Previsione

Precedente Chiudi:

$3.30

Aprire:

$3.27

Volume 24 ore:

3.59M

Relative Volume:

1.47

Capitalizzazione di mercato:

$500.29M

Reddito:

$38.69M

Utile/perdita netta:

$-108.95M

Rapporto P/E:

-2.6667

EPS:

-1.2225

Flusso di cassa netto:

$-141.09M

1 W Prestazione:

-10.68%

1M Prestazione:

+31.45%

6M Prestazione:

+57.49%

1 anno Prestazione:

+6.54%

Intervallo 1D:

$2.96

$3.28

Intervallo di 1 settimana:

$2.96

$3.815

Portata 52W:

$1.66

$4.5372

Editas Medicine Inc Stock (EDIT) Company Profile

Nome

Editas Medicine Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

617-401-9000

Indirizzo

11 HURLEY ST., CAMBRIDGE, MA

Dipendente

Cinguettio

@editasmed

Prossima data di guadagno

2026-08-11

Ultimi documenti SEC

EDIT's Discussions on Twitter

Compare EDIT vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EDIT Editas Medicine Inc	3.26	500.29M	38.69M	-108.95M	-141.09M	-1.2225
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Editas Medicine Inc Stock (EDIT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-28	Iniziato	H.C. Wainwright	Buy
2024-12-16	Downgrade	JP Morgan	Neutral → Underweight
2024-12-13	Downgrade	Chardan Capital Markets	Buy → Neutral
2024-12-13	Downgrade	Stifel	Buy → Hold
2024-12-13	Downgrade	Truist	Buy → Hold
2024-12-11	Downgrade	Wells Fargo	Overweight → Equal Weight
2024-11-25	Downgrade	BofA Securities	Buy → Underperform
2024-11-06	Aggiornamento	Evercore ISI	In-line → Outperform
2024-11-04	Downgrade	Raymond James	Outperform → Mkt Perform
2024-08-08	Aggiornamento	BofA Securities	Neutral → Buy
2024-05-09	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2023-10-24	Aggiornamento	Citigroup	Neutral → Buy
2023-10-18	Aggiornamento	JP Morgan	Underweight → Neutral
2023-10-17	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-09-29	Aggiornamento	Stifel	Hold → Buy
2023-06-12	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-02-01	Iniziato	Cantor Fitzgerald	Overweight
2022-12-13	Iniziato	Citigroup	Neutral
2022-12-06	Ripresa	Credit Suisse	Neutral
2022-11-18	Downgrade	Credit Suisse	Outperform → Neutral
2022-11-18	Downgrade	Oppenheimer	Outperform → Perform
2022-09-29	Iniziato	BofA Securities	Neutral
2021-10-19	Iniziato	SVB Leerink	Mkt Perform
2021-09-24	Iniziato	Stifel	Hold
2021-09-10	Aggiornamento	Oppenheimer	Perform → Outperform
2021-08-09	Aggiornamento	Truist	Hold → Buy
2021-08-05	Aggiornamento	Evercore ISI	Underperform → Outperform
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-05-04	Iniziato	RBC Capital Mkts	Sector Perform
2021-04-16	Iniziato	Goldman	Sell
2021-03-22	Iniziato	Credit Suisse	Outperform
2021-03-01	Downgrade	Barclays	Overweight → Equal Weight
2021-02-26	Downgrade	Truist	Buy → Hold
2021-01-19	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2021-01-07	Downgrade	Raymond James	Outperform → Mkt Perform
2020-12-10	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2020-11-03	Iniziato	Robert W. Baird	Underperform
2020-06-18	Ripresa	SunTrust	Buy
2020-02-21	Iniziato	Wells Fargo	Equal Weight
2019-04-12	Iniziato	Evercore ISI	Outperform
2018-10-10	Iniziato	Guggenheim	Neutral
2018-09-21	Iniziato	Raymond James	Outperform
2018-05-15	Reiterato	Chardan Capital Markets	Buy
2018-02-13	Iniziato	CLSA	Underperform
2018-01-23	Aggiornamento	SunTrust	Hold → Buy
2017-07-14	Iniziato	SunTrust	Hold
2017-03-28	Iniziato	Chardan Capital Markets	Buy
2016-08-10	Aggiornamento	Jefferies	Hold → Buy
2016-06-02	Iniziato	Jefferies	Hold
2016-02-29	Iniziato	JMP Securities	Mkt Outperform
2016-02-29	Iniziato	JP Morgan	Neutral
2016-02-29	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Editas Medicine Inc Borsa (EDIT) Ultime notizie

Jul 09, 2026

What pharma leaders wish they knew on day 1 - Pharma Voice

Jul 09, 2026

Jul 04, 2026

Editas Medicine appoints PwC as new auditor, dismisses Ernst & Young - Investing.com

Jul 04, 2026

Jul 03, 2026

Editas Medicine stock holds the line as pipeline work continues. - ad-hoc-news.de

Jul 03, 2026

Jul 02, 2026

EDIT's Q1 loss narrower than expected, pipeline in focus - MSN

Jul 02, 2026

Jun 29, 2026

Editas Medicine, Inc.(NasdaqGS:EDIT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026

Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of Editas Medicine, Inc. – NASDAQ:EDIT - TradingView

Jun 27, 2026

Price to earnings forward of Editas Medicine, Inc. – LSE:0IFK - TradingView

Jun 27, 2026

Enterprise value to revenue forward of Editas Medicine, Inc. – NASDAQ:EDIT - TradingView

Jun 27, 2026

EDIT Q1 2026 Earnings: Narrowing Losses Amid Pipeline ProgressMid-Term Outlook - dars.gov.et

Jun 27, 2026

Price to book forward of Editas Medicine, Inc. – NASDAQ:EDIT - TradingView

Jun 27, 2026

Jun 26, 2026

Editas Medicine, Inc. Actuals & Estimates (NASDAQ:EDIT) - TradingView

Jun 26, 2026

Enterprise value to EBITDA forward of Editas Medicine, Inc. – LSE:0IFK - TradingView

Jun 26, 2026

Editas Medicine, Inc. Actuals & Estimates (LSE:0IFK) - TradingView

Jun 26, 2026

EDIT Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Editas Medicine, Inc. Actuals & Estimates (FWB:8EM) - TradingView

Jun 26, 2026